ENDRA Life Sciences (NDRA) Cash & Equivalents (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Cash & Equivalents of $356462.0 for Q1 2026, down 82.74% year-over-year from $2.1 million in Q1 2025, and down 53.24% quarter-over-quarter from $762365.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Cash & Equivalents (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Cash & Equivalents for 11 consecutive years, with $356462.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents fell 82.74% year-over-year to $356462.0; the TTM figure through Mar 2026 stood at $356462.0 (down 82.74% YoY), while the FY2025 annual figure was $762365.0, down 76.39% from the prior year.
- Cash & Equivalents fell to $356462.0 in Q1 2026 per NDRA's latest filing, from $762365.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $11.3 million in Q2 2022 and bottomed at $356462.0 in Q1 2026.
- Historically, Cash & Equivalents has averaged $3.9 million across 5 years, with a median of $3.2 million in 2024.
- On a YoY basis, Cash & Equivalents climbed as much as 81.98% in 2025 and fell as far as 83.27% in 2025.
- ENDRA Life Sciences' Cash & Equivalents stood at $4.9 million in 2022, then slumped by 42.04% to $2.8 million in 2023, then increased by 13.96% to $3.2 million in 2024, then tumbled by 76.39% to $762365.0 in 2025, then slumped by 53.24% to $356462.0 in 2026.
- Business Quant data shows NDRA's Cash & Equivalents at $356462.0 in Q1 2026, $762365.0 in Q4 2025, and $794036.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 4.06 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 4.35 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 196.93 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 1.81 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 1.91 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 1.10 Bn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 1.04 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 51.40 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 626.00 Mn |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | 356,462.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 356,462.00 |
| Dec 31, 2025 | 762,365.00 |
| Sep 30, 2025 | 794,036.00 |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Sep 30, 2024 | 4.75 Mn |
| Jun 30, 2024 | 6.40 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 2.83 Mn |
| Sep 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 4.82 Mn |
| Mar 31, 2023 | 2.36 Mn |
| Dec 31, 2022 | 4.89 Mn |
| Sep 30, 2022 | 8.02 Mn |
| Jun 30, 2022 | 11.28 Mn |
| Mar 31, 2022 | 7.13 Mn |
| Dec 31, 2021 | 9.46 Mn |
| Sep 30, 2021 | 11.79 Mn |
| Jun 30, 2021 | 14.04 Mn |